apl. Prof. Dr. Alexander Hein

Department of Obstetrics and Gynaecology Medizinische Fakultät

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, et al. Journal article Two truncating variants in FANCC and breast cancer risk (2019) Dork T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, et al. Journal article Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study (2019) Wallwiener M, Nabieva N, Feisst M, Fehm T, De Waal J, Rezai M, Baier B, et al. Journal article Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer (2019) Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fießler C, Hein A, et al. Journal article Genome-wide association study of germline variants and breast cancer-specific mortality (2019) Escala-Garcia M, Guo Q, Doerk T, Canisius S, Keeman R, Dennis J, Beesley J, et al. Journal article Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus (2019) Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandino G, Lawrenson K, Hazelett DJ, Najafabadi HS, et al. Journal article Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma (2019) Hein A, Schneider M, Renner S, Fasching P, Fießler C, Titz S, Hartmann A, et al. Journal article Standard changing news der Senologie und der Gynäkologischen Onkologie 2019: Neue Arzneimittelzulassungen und Änderungen bestehender Therapiekonzepte (2019) Preuβ C, Hein A, Beckmann M, Jud S Journal article Primäre Prävention - Mamma- und Genitalkarzinome (2019) Preu C, Heindl F, Hein A, Koch M, Ga P, Beckmann M, Lux MP, Emons J Journal article Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) Fasching P, Gaß P, Häberle L, Volz B, Hein A, Hack C, Lux MP, et al. Journal article